🇺🇸 FDA
Patent

US 9562070

Induction of tumor immunity by variants of folate binding protein

granted A61KA61K2039/54A61K2039/545

Quick answer

US patent 9562070 (Induction of tumor immunity by variants of folate binding protein) held by The Board of Regents of the University of Texas System expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K2039/54, A61K2039/545, A61K38/00, A61K39/00